Healthcare Reports

Trends, opportunity and forecast in hepatitis A vaccine market in Canada to 2030 by type (inactivated vaccine and live attenuated vaccine) and application (government institution, private sector, and others)

Trends, opportunity and forecast in diphtheria vaccine market in Canada to 2030 by vaccine type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine) and end use (hospitals, clinics, vaccination centers, and others)

Trends, opportunity and forecast in adult vaccine market in Canada to 2030 by technology (live attenuated, inactivated, subunit, toxoid, conjugate , and others), vaccine type (monovalent and multivalent), and end use (private healthcare firms and government hospitals)

Trends, opportunity and forecast in dog vaccine market in Canada to 2030 by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, dna vaccines, and recombinant vaccine), age (below 6 months and above 6 months), and end use (veterinary hospitals & clinics, pet owners, and others)

Trends, opportunity and forecast in chickenpox vaccine market in Canada to 2030 by product type (monovalent vaccine and combination vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), and end use (hospitals, clinics, and others)

Trends, opportunity and forecast in cat vaccine market in Canada to 2030 by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, dna vaccines, and recombinant vaccines), age (below 6 months and above 6 months), and distribution channel (veterinary clinics, pet stores, and online retailers)

Trends, opportunity and forecast in mRNA vaccine market in Canada to 2030 by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), and end use (hospitals & clinics, research laboratories, and others)

Trends, opportunity and forecast in malaria vaccine market in Canada to 2030 by type (pre-erythrocytic, erythrocytic, multi-antigen, and others), agent (plasmodium falciparum, plasmodium vivax, and anopheles species), and end use (hospitals, specialty clinics, homecare, and others)

Trends, opportunity and forecast in companion animal vaccine market in Canada to 2030 by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), and end use (hospitals & clinics, research institutes, and others)

Trends, opportunity and forecast in toxoid vaccine market in Canada to 2030 by vaccine type (diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (TDaP), and others), end use (hospitals, specialty centre, governments organization, and others)

Trends, opportunity and forecast in multivalent vaccine market in Canada to 2030 by type (conjugate vaccine, inactivated and subunit vaccine, and live attenuated vaccine), and application (pediatrics and adults)

Trends, opportunity and forecast in live attenuated vaccine market in Canada to 2030 by type (bacterial and viral), and end use (hospital, clinic, diagnostics center, research institute, and others)

Trends, opportunity and forecast in adenovirus vaccine market to 2030 by type (type 4 vaccine and type 7 vaccine), application (research and academic, laboratories, and pharmaceutical & biotechnology), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in typhoid fever vaccine market in Canada to 2030 by type (live attenuated vaccine, capsular polysaccharide vaccine, conjugate vaccine, and others), route of administration (oral and injection), and end use (hospitals & clinics, specialty centers, and others)

Trends, opportunity and forecast in respiratory virus vaccine market in Canada to 2030 by type (inactivated/killed, live-attenuated, and recombinant), route of administration (intramuscular, intranasal, and subcutaneous), indication (influenza, measles, mumps & rubella, and coronavirus), and end use (physician offices, hospitals, clinics, pharmacies/stores, and others)

Trends, opportunity and forecast in rabies vaccine market in Canada to 2030 by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), and end use (hospitals, homecare, specialty clinics, and others)

Trends, opportunity and forecast in pet vaccine market in Canada to 2030 by type (canlane and feline), vaccination (canine family, core vaccines, and non-core vaccines), mode of administration (injectable vaccines and intranasal vaccines), and application (dogs, cats, rabbits, and others)

Trends, opportunity and forecast in Japanese encephalitis vaccine market in Canada to 2030 by type (inactivated, recombinant, and live attenuated), distribution channel (hospitals, retail, and online), and application (pediatric vaccines and adult vaccines)

Trends, opportunity and forecast in ebola drug and vaccine market in Canada to 2030 by novel drug type (zmapp, favipiravir, gs-5734, tkm-ebola, and avi-7537), vaccine type (cad3-zebov, rvsv-zebov, and others), strain type (zaire, sudan, tai forest, reston, and bundibugyo virus), and end use (hospitals & clinics, ambulatory surgical centers, and others)

Trends, opportunity and forecast in thyroid eye disease market in Canada to 2030 by treatment type (corticosteroids, vitamins, and monoclonal antibody), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), and end use industry (hospitals, and clinics)

Trends, opportunity and forecast in oropharyngeal cancer diagnosis and therapeutics market in Canada to 2030 by type (endoscopy, biopsy, imaging, MRI scan, CT scan, and pet-CT scan), treatment (surgery, chemotherapy, radiation therapy, targeted therapy, and others), and end use (hospitals, ambulatory surgery centers, and others)

Trends, opportunity and forecast in autoimmune hepatitis diagnosis and treatment market in Canada to 2030 by type (type-i, type-ii, and variant AIH), diagnosis (blood test, imaging test, and liver biopsy), treatment (medication, corticosteroids, immune system suppressors, and liver transplant), end use industry (hospitals & clinics, diagnostic centre, and research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World).type (type-I, type-II, and variant AIH), diagnosis (blood test, imaging test, and liver biopsy), treatment (medication, corticosteroids, immune system suppressors, and liver transplant), and end use industry (hospitals & clinics, diagnostic centre, research institutions, and others)

Trends, opportunities, and forecast for the brain health supplement market in Canada from 2017 to 2028 by product product (natural molecules, herbal extract, and vitamins & minerals), application (memory enhancement, attention & focus, depression & mood, sleep and recovery, anti-aging & longevity, and stress & anxiety)